相关实验视频

Updated: Jan 12, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

在早期手术性大动脉生物假体失败后,第二次生物假体的三年结果

Le Nguyen¹, Evan Walser-Kuntz¹, Larissa Stanberry¹

¹Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.

|November 6, 2025

概括

为早期结构恶化 (SVD) 进行重复大动脉置换 (AVR) 显示了高复发率的SVD,特别是在门中透管AVR后的第一年内. 剩余的血液动力学问题预测了早期的生物假体门失效.

科学领域:

心脏病学心脏病学
生物医学工程生物医学工程
手术创新在外科创新.

背景情况:

生物假体大动脉对于65岁以上的患者至关重要,但由于结构损坏 (SVD) 的有限耐用性,需要重复手术.
对于早期SVD (5年内) 进行重复大动脉置换 (AVR) 的数据有限,这突显了了解长期结果的差距.

研究的目的:

评估在SVD早期重复AVR后的3年血液动力学结果.
为了确定重复AVR后复发性SVD的发生率,比较外科手术大动脉置换 (SAVR) 和透气管大动脉置换 (TAVR) 策略.

主要方法:

在SAVR (2012-2022) 之后,对92名接受SVD早期再干预的患者进行了回顾性研究.
分析包括患有重复SAVR (n=16) 或门内门TAVR (n=76) 的患者.
主要终点:5年内第二次生物假体的早期SVD;次要结果:死亡率,心力衰竭和中风.

主要成果:

复发的早期SVD发生在21.7%的患者中,65%的病例发生在重新干预后的第一年内.
虽然在统计学上没有显著性,但SAVR后的TAVR显示了复发早期SVD的更高率 (23.7%),相比于SAVR后的SAVR (12.5%).
复发性早期SVD的独立预测因素包括平均梯度升高,大动脉膜面积减少以及在放电或30天后中度/严重的大动脉吐.

结论:

在重复AVR后的早期生物假体门故障,特别是门内门TAVR,经常发生在第一年内.
在排出时发现的残留血液动力学异常是第二个生物假体中早期结构恶化的强有力的预测因素.

关键词:

临床结果的临床结果.失败的生物假体在手术前进行大动脉置换手术.结构的恶化结构的恶化门血动力学门血动力学门中的门 TAVRR

更多相关视频

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

相关概念视频

Aneurysm III: Interprofessional Care

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...